Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...

Moderna shares are volatile Monday after the company provided updates on its business and pipeline at a healthcare conference ...

On Tuesday, Moderna MRNA got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 73. This exclusive rating ...

Moderna (MRNA) closed at $40.60 in the latest trading session, marking a +2.52% move from the prior day. The stock's change ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.

Argus Research analyst Jasper Hellweg reiterated a Hold rating on Moderna yesterday. The company’s shares closed yesterday at $39.60. According to TipRanks, Hellweg is a 4-star analyst with an average ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...

In addition to Jefferies, Moderna also received a Hold from Morgan Stanley’s Terence Flynn in a report issued today. However, yesterday, Piper Sandler reiterated a Buy rating on Moderna (NASDAQ: MRNA) ...

Caterpillar CAT stock rose toward closing with a market cap of more than $300 billion for the first time ever, according to ...

These days, an S&P 500 fund is less a diversified investment than a bet on whether AI will pay off for a handful of the world’s biggest companies.